The Department of Defense is offering the Tuberous Sclerosis Complex Idea Development Award to support innovative and high-impact research projects in the early stages of development. This grant aims to fund research that could lead to significant discoveries in TSC research or improvements in patient care. Applicants are encouraged to propose new ideas with strong scientific rationale and articulate the short- and long-term impact of their research. While human subjects research is allowed, clinical trials are not permitted under this funding opportunity. The closing date for applications is July 24, 2014.
Opportunity ID: 256019
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-TSCRP-IDA |
| Funding Opportunity Title: | DoD Tuberous Sclerosis Complex Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 27, 2014 |
| Last Updated Date: | May 28, 2014 |
| Original Closing Date for Applications: | Jul 24, 2014 |
| Current Closing Date for Applications: | Jul 24, 2014 |
| Archive Date: | Aug 23, 2014 |
| Estimated Total Program Funding: | $2,960,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The TSCRP Idea Development Award mechanism was first offered in FY02. Since then, 230 Idea Development Award applications have been received, and 45 have been recommended for funding.The FY14 TSCRP Idea Development Award promotes new ideas that are in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.The following are important aspects of the Idea Development Award:1. Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities that may include high-risk/potentially high-gain approaches to TSC research. Research that is merely an incremental advance (the next logical step) is not considered innovative.2. Impact: Applications should articulate both the short- and long-term impact of the proposed research. High-impact research will, if successful, significantly advance TSC research and/or patient care.3. Preliminary Data: Preliminary data, unpublished results from the laboratory of the Principal Investigator (PI) or collaborators named on this application, and/or data from the published literature that are relevant to TSC and the proposed research project should be included.Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. For more information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the Congressionally Directed Medical Research Programs (CDMRP) electronic Biomedical Research Application Portal (eBRAP) system at https://ebrap.org/eBRAP/public/Program.htm. PIs wishing to apply for funding for a clinical trial should utilize the FY14 TSCRP Pilot Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-14-TSCRP-PCTA). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Phone: 301-682-5507
Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modification necessary to correct Estimated Total Program Funding. | May 28, 2014 | |
| May 28, 2014 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-TSCRP-IDA |
| Funding Opportunity Title: | DoD Tuberous Sclerosis Complex Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 27, 2014 |
| Last Updated Date: | May 28, 2014 |
| Original Closing Date for Applications: | Jul 24, 2014 |
| Current Closing Date for Applications: | Jul 24, 2014 |
| Archive Date: | Aug 23, 2014 |
| Estimated Total Program Funding: | $2,960,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The TSCRP Idea Development Award mechanism was first offered in FY02. Since then, 230 Idea Development Award applications have been received, and 45 have been recommended for funding.The FY14 TSCRP Idea Development Award promotes new ideas that are in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.The following are important aspects of the Idea Development Award:1. Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities that may include high-risk/potentially high-gain approaches to TSC research. Research that is merely an incremental advance (the next logical step) is not considered innovative.2. Impact: Applications should articulate both the short- and long-term impact of the proposed research. High-impact research will, if successful, significantly advance TSC research and/or patient care.3. Preliminary Data: Preliminary data, unpublished results from the laboratory of the Principal Investigator (PI) or collaborators named on this application, and/or data from the published literature that are relevant to TSC and the proposed research project should be included.Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. For more information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the Congressionally Directed Medical Research Programs (CDMRP) electronic Biomedical Research Application Portal (eBRAP) system at https://ebrap.org/eBRAP/public/Program.htm. PIs wishing to apply for funding for a clinical trial should utilize the FY14 TSCRP Pilot Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-14-TSCRP-PCTA). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Phone: 301-682-5507
Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-TSCRP-IDA |
| Funding Opportunity Title: | DoD Tuberous Sclerosis Complex Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 28, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 24, 2014 |
| Archive Date: | Aug 23, 2014 |
| Estimated Total Program Funding: | $2,096,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The TSCRP Idea Development Award mechanism was first offered in FY02. Since then, 230 Idea Development Award applications have been received, and 45 have been recommended for funding.
The FY14 TSCRP Idea Development Award promotes new ideas that are in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. The following are important aspects of the Idea Development Award: 1. Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities that may include high-risk/potentially high-gain approaches to TSC research. Research that is merely an incremental advance (the next logical step) is not considered innovative. 2. Impact: Applications should articulate both the short- and long-term impact of the proposed research. High-impact research will, if successful, significantly advance TSC research and/or patient care. 3. Preliminary Data: Preliminary data, unpublished results from the laboratory of the Principal Investigator (PI) or collaborators named on this application, and/or data from the published literature that are relevant to TSC and the proposed research project should be included. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. For more information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the Congressionally Directed Medical Research Programs (CDMRP) electronic Biomedical Research Application Portal (eBRAP) system at https://ebrap.org/eBRAP/public/Program.htm. PIs wishing to apply for funding for a clinical trial should utilize the FY14 TSCRP Pilot Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-14-TSCRP-PCTA). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Phone: 301-682-5507
Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Folder 256019 Full Announcement-1 -> TSCRP_FY14 IDA PA_GG.pdf
Packages
| Agency Contact Information: | Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00197410 | May 27, 2014 | Jul 24, 2014 | View |
Package 1
Mandatory forms
256019 RR_SF424_2_0-2.0.pdf
256019 RR_Budget_1_3-1.3.pdf
256019 RR_KeyPersonExpanded_2_0-2.0.pdf
256019 PerformanceSite_2_0-2.0.pdf
Optional forms
256019 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
